423 related articles for article (PubMed ID: 9292940)
1. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis.
Bogazzi F; Bartalena L; Brogioni S; Mazzeo S; Vitti P; Burelli A; Bartolozzi C; Martino E
Thyroid; 1997 Aug; 7(4):541-5. PubMed ID: 9292940
[TBL] [Abstract][Full Text] [Related]
2. Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
Loy M; Perra E; Melis A; Cianchetti ME; Piga M; Serra A; Pinna G; Mariotti S
Acta Radiol; 2007 Jul; 48(6):628-34. PubMed ID: 17611870
[TBL] [Abstract][Full Text] [Related]
3. Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis.
Bogazzi F; Martino E; Dell'Unto E; Brogioni S; Cosci C; Aghini-Lombardi F; Ceccarelli C; Pinchera A; Bartalena L; Braverman LE
J Endocrinol Invest; 2003 Jul; 26(7):635-40. PubMed ID: 14594114
[TBL] [Abstract][Full Text] [Related]
4. Amiodarone-induced thyrotoxicosis. A review.
Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S
Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027
[TBL] [Abstract][Full Text] [Related]
5. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study.
Bartalena L; Brogioni S; Grasso L; Bogazzi F; Burelli A; Martino E
J Clin Endocrinol Metab; 1996 Aug; 81(8):2930-3. PubMed ID: 8768854
[TBL] [Abstract][Full Text] [Related]
6. Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography.
Bogazzi F; Bartalena L; Brogioni S; Burelli A; Manetti L; Tanda ML; Gasperi M; Martino E
Eur J Endocrinol; 1999 May; 140(5):452-6. PubMed ID: 10229913
[TBL] [Abstract][Full Text] [Related]
7. Approach to the patient with amiodarone-induced thyrotoxicosis.
Bogazzi F; Bartalena L; Martino E
J Clin Endocrinol Metab; 2010 Jun; 95(6):2529-35. PubMed ID: 20525904
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
Sato K; Miyakawa M; Eto M; Inaba T; Matsuda N; Shiga T; Ohnishi S; Kasanuki H
Endocr J; 1999 Jun; 46(3):443-51. PubMed ID: 10503998
[TBL] [Abstract][Full Text] [Related]
9. The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
Piga M; Cocco MC; Serra A; Boi F; Loy M; Mariotti S
Eur J Endocrinol; 2008 Oct; 159(4):423-9. PubMed ID: 18603573
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography.
Eaton SE; Euinton HA; Newman CM; Weetman AP; Bennet WM
Clin Endocrinol (Oxf); 2002 Jan; 56(1):33-8. PubMed ID: 11849244
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of amiodarone-induced thyrotoxicosis: evaluation of colour-flow Doppler sonography in predicting therapeutic response.
Wong R; Cheung W; Stockigt JR; Topliss DJ
Intern Med J; 2003; 33(9-10):420-6. PubMed ID: 14511194
[TBL] [Abstract][Full Text] [Related]
12. Serum interleukin-6 in amiodarone-induced thyrotoxicosis.
Bartalena L; Grasso L; Brogioni S; Aghini-Lombardi F; Braverman LE; Martino E
J Clin Endocrinol Metab; 1994 Feb; 78(2):423-7. PubMed ID: 8106631
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis and clinical course of amiodarone-induced thyroid dysfunction.
Alyan O; Arda K; Ozdemir O; Acu B; Soylu M; Demirkan D
Med Sci Monit; 2003 Sep; 9(9):PI117-22. PubMed ID: 12960935
[TBL] [Abstract][Full Text] [Related]
14. [Amiodarone and the thyroid gland].
Bednarek-Tupikowska G; Filus A; Kuliczkowska J; Bugajski J
Postepy Hig Med Dosw (Online); 2004 Apr; 58():216-25. PubMed ID: 15114257
[TBL] [Abstract][Full Text] [Related]
15. Color flow Doppler sonography in thyrotoxicosis factitia.
Bogazzi F; Bartalena L; Vitti P; Rago T; Brogioni S; Martino E
J Endocrinol Invest; 1996 Oct; 19(9):603-6. PubMed ID: 8957744
[TBL] [Abstract][Full Text] [Related]
16. A stepwise approach to the treatment of amiodarone-induced thyrotoxicosis.
Erdogan MF; Güleç S; Tutar E; Başkal N; Erdogan G
Thyroid; 2003 Feb; 13(2):205-9. PubMed ID: 12699596
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association.
Bartalena L; Wiersinga WM; Tanda ML; Bogazzi F; Piantanida E; Lai A; Martino E
Clin Endocrinol (Oxf); 2004 Oct; 61(4):494-502. PubMed ID: 15473883
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of
Wang J; Zhang R
Br J Radiol; 2017 Mar; 90(1071):20160836. PubMed ID: 28106465
[TBL] [Abstract][Full Text] [Related]
19. Amiodarone-induced thyrotoxicosis due to destructive thyroiditis: therapeutic recommendations.
Dietlein M; Schicha H
Exp Clin Endocrinol Diabetes; 2005 Mar; 113(3):145-51. PubMed ID: 15789273
[TBL] [Abstract][Full Text] [Related]
20. 99mTc Sestamibi Thyroid Scan in Amiodarone-Induced Thyrotoxicosis Type I.
Patel NR; Tamara LA; Lee H
Clin Nucl Med; 2016 Jul; 41(7):566-7. PubMed ID: 27163459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]